1. Home
  2. SNSC vs HRTX Comparison

SNSC vs HRTX Comparison

Compare SNSC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SNSC

SunScout Holding Limited Class A Ordinary Shares

N/A

Current Price

$1.25

Market Cap

51.4M

Sector

N/A

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$0.35

Market Cap

61.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNSC
HRTX
Founded
1998
1983
Country
New Zealand
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
61.2M
IPO Year
2026
2007

Fundamental Metrics

Financial Performance
Metric
SNSC
HRTX
Price
$1.25
$0.35
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
39.5K
★ 1.8M
Earning Date
11-19-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $154,904,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.36
52 Week Low
$1.00
$0.26
52 Week High
$3.07
$1.58

Technical Indicators

Market Signals
Indicator
SNSC
HRTX
Relative Strength Index (RSI) 32.81 49.48
Support Level $1.00 $0.30
Resistance Level N/A $0.34
Average True Range (ATR) 0.11 0.02
MACD 0.07 0.00
Stochastic Oscillator 62.07 75.62

Price Performance

Historical Comparison
SNSC
HRTX

About SNSC SunScout Holding Limited Class A Ordinary Shares

SunScout Holding Ltd is a clean-technology company engaged in the design, development, manufacturing, and commercialization of autonomous, solar-powered robotic mowers and related solar energy solutions. Its products are intended as alternatives to petrol-powered and grid-dependent electric lawn mowing equipment. The company's business comprises three lines of products and solutions, which are also its reportable segments: SunScout Products, Solar Power Development Solutions, and Engineering Products and Services. The majority of revenue is derived from the Solar Power Development Solutions segment, which develops and installs solar-energy systems for commercial, industrial, and institutional customers through EPC contracts. Geographically, maximum revenue is derived from New Zealand.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: